BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15953021)

  • 1. Vancomycin-resistant enterococci: consequences for therapy and infection control.
    Mascini EM; Bonten MJ
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():43-56. PubMed ID: 15953021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vancomycin resistant enterococci in the Netherlands].
    Leavis HL; Willems RJ; Mascini EM; Vandenbroucke-Grauls CM; Bonten MJ
    Ned Tijdschr Geneeskd; 2004 May; 148(18):878-82. PubMed ID: 15152389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin-resistant enterococci: why are they here, and where do they come from?
    Bonten MJ; Willems R; Weinstein RA
    Lancet Infect Dis; 2001 Dec; 1(5):314-25. PubMed ID: 11871804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z; Cao B; Liu YM; Gu L; Wang C
    Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci.
    Sakka V; Tsiodras S; Galani L; Antoniadou A; Souli M; Galani I; Pantelaki M; Siafakas N; Zerva L; Giamarellou H
    Clin Microbiol Infect; 2008 Jan; 14(1):14-21. PubMed ID: 18005178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What is to be done with vancomycin-resistant enterococcal infections?].
    Bonten MJ; Mascini EM; Willems R; Timmer GJ; Gaillard CA; Vandenbroucke-Grauls CM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(53):2545-9. PubMed ID: 11191789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outbreak of hospital-adapted clonal complex-17 vancomycin-resistant Enterococcus faecium strain in a haematology unit: role of rapid typing for early control.
    Deplano A; Denis O; Nonhoff C; Rost F; Byl B; Jacobs F; Vankerckhoven V; Goossens H; Struelens MJ
    J Antimicrob Chemother; 2007 Oct; 60(4):849-54. PubMed ID: 17650516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantially increased faecal carriage of vancomycin-resistant enterococci in a tertiary Greek hospital after a 4 year time interval.
    Sofianou D; Pournaras S; Giosi M; Polyzou A; Maniatis AN; Tsakris A
    J Antimicrob Chemother; 2004 Jul; 54(1):251-4. PubMed ID: 15163658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vancomycin resistant enterococci].
    Fujita N; Komori T; Ike Y; Yoshimura M
    Rinsho Byori; 1998 Jul; 46(7):629-36. PubMed ID: 9721528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of vancomycin-resistant enterococci: one size fits all?
    Armeanu E; Bonten MJ
    Clin Infect Dis; 2005 Jul; 41(2):210-6. PubMed ID: 15983917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissemination of vancomycin-resistant enterococci among haemodialysis patients in Athens, Greece.
    Kalocheretis P; Baimakou E; Zerbala S; Papaparaskevas J; Makriniotou I; Tassios PT; Iatrou C; Kouskouni E; Zerva L
    J Antimicrob Chemother; 2004 Dec; 54(6):1031-4. PubMed ID: 15498878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiological search for vancomycin-resistant enterococci in mainland of the Ryukyus].
    Kisanuki K; Higa M; Nakasone I; Shiohira CM; Yamane N
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2008; 19(1-2):1-6. PubMed ID: 19583456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
    Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital.
    Ergani-Ozcan A; Naas T; Baysan BO; Ogunc D; Inan D; Colak D; Nordmann P
    J Antimicrob Chemother; 2008 May; 61(5):1033-9. PubMed ID: 18319236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin-resistant enterococci (VRE): transmission and control.
    Tacconelli E; Cataldo MA
    Int J Antimicrob Agents; 2008 Feb; 31(2):99-106. PubMed ID: 18164908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci.
    Hayden MK
    Clin Infect Dis; 2000 Oct; 31(4):1058-65. PubMed ID: 11049790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vancomycin resistant enterococcal infections and detection of their resistance genes].
    Fujita N
    Rinsho Byori; 2002 Nov; Suppl 123():62-70. PubMed ID: 12652792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vancomycin resistant Enterococci (VRE)].
    Lesens O
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S261-4. PubMed ID: 19596346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonization with vancomycin-resistant enterococci (VRE) in intensive care unit patients in Cordoba City, Argentina.
    Littvik AM; López TN; González SE; Fernández CM; Pavan JV
    Rev Argent Microbiol; 2006; 38(1):28-30. PubMed ID: 16784130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.